Accession Number: | 0001209191-19-059988 |
Date: | 2019-12-09 |
Issuer: | MAGELLAN HEALTH INC (MGLN) |
Original Submission Date: |
KAMAL MOSTAFA
15950 NORTH 76TH STREET
SUITE 200
SCOTTSDALE, AZ 85260
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
ORDINARY COMMON STOCK, $0.01 PAR VALUE | 2019-12-09 | X | 16,666 | a | $60.55 | 19,459 | direct | ||
ORDINARY COMMON STOCK, $0.01 PAR VALUE | 2019-12-09 | X | 100 | a | $64.87 | 19,559 | direct | ||
ORDINARY COMMON STOCK, $0.01 PAR VALUE | 2019-12-09 | S | 16,766 | d | $78.72 | 2,793 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 60.55 | 2019-12-09 | deemed execution date | X | 16,666 (d) | 2025-08-03 | common stock 16,666 | $60.55 | 0 | direct | ||
STOCK OPTION (RIGHT TO BUY) | 64.87 | 2019-12-09 | deemed execution date | X | 100 (d) | 2026-03-03 | common stock 100 | $64.87 | 7,206 | direct |
ID | footnote |
---|---|
f1 | this transaction was effectuated pursuant to a rule 10b-5-1 plan. |
f2 | the number of securities reported represents an aggregate number of shares sold in multiple open market transactions at prices ranging from $78.15 to $80.00, inclusive. the price reported represents the weighted average price. the reporting person undertakes to provide staff of the sec, the issuer, or a stockholder of the issuer, upon request, the number of shares sold by the reporting person at each separate price within the range. |
f3 | all of the stock options in this tranche have vested in full. |
f4 | not applicable. |